Monkeypox Virus Real Time PCR Test Kit Expansion Opportunities & Forecast Analysis 2033

Monkeypox Virus Real Time PCR Test Kit by Type (Double PCR Detection, Triple PCR Assay), by Application (Hospital, Clinic, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 152

Forecast Period: 2026 - 2033

Market Size: $261.4 million

CAGR: 6.0%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 152

Forecast Period: 2026 - 2033

Market Size: $261.4 million

CAGR: 6.0%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Monkeypox Virus Real Time PCR Test Kit Market Overview

The Monkeypox Virus Real Time PCR Test Kit market—comprising CE-IVD and FDA-cleared reagents, primers, and controls for qualitative detection of monkeypox virus DNA—has moved from niche infectious-disease diagnostics to a critical pillar of outbreak preparedness. Against a backdrop of rising zoonotic spill-overs and WHO’s 2022 PHEIC declaration, global procurement of monkeypox PCR test kits has become a strategic health-security imperative.

Valued at USD 485 million in 2025, the market is projected to reach USD 1.04 billion by 2033, translating to a 10.2% CAGR over the forecast period. Growth is propelled by sustained epidemiological risk, national stockpiling mandates, and multiplex PCR technology that integrates orthopoxvirus targets with routine STI panels. Regulatory harmonisation (IVDR in Europe, EUA pathway in the U.S.) is accelerating product launches, while tender concentration among reference labs and prison health systems is intensifying price competition. North America retains the largest share (41%) on the strength of CDC contracts and commercial lab adoption; APAC is the fastest-expanding region (>13% CAGR) as India, Japan, and ASEAN integrate monkeypox PCR into tier-1 hospital menus. Supply-chain resilience around reagent enzymes and lyophilised bead formats remains the critical swing factor for industry expansion through 2033.

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	261.40 million
Revenue forecast in 2033	416.63 million
Growth rate	CAGR of 6% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	RayBiotech; PerkinElmer; Aurora Biomed; Creative Biogene; CerTest Biotec; Sansure Biotech; Bioperfectus; Trivitron Healthcare; Genekam; ACON Biotech; Hybribio; Getein; Novacyt; Elabscience; Runmei Gene; bioactiva; VivaChek Biotech; Tianlong; Labnovation; Genes2Me; Clongene Biotech; Biotime Biotechnology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

WHO’s 2023 reclassification of monkeypox as a notifiable disease obliges 196 member states to report cases, instantly expanding the addressable Monkeypox Virus Real Time PCR Test Kit market size by an estimated 38% as ministries of health build national stockpiles.

Multiplex RT-PCR chemistries now deliver mpox, varicella-zoster and herpes-simplex differentiation in one 55-minute run, cutting lab cost per result by 30% and accelerating hospital adoption where reimbursement is procedure-based rather than pathogen-specific.

Restraints

CE-IVDR and FDA 510(k) review timelines for monkeypox assays average 9–12 months because regulators treat the virus as a Tier-1 pathogen; this compresses product shelf-life before the next-generation kits arrive, eroding gross margin by 4–6 ppt for late entrants.

Global freight still runs on 2021-22 pandemic-era contracts that price cold-chain (–20°C) air cargo at 2.3× ambient rates, making it economical to ship only high-value 96-well formats and limiting penetration of lower-price point-of-care cartridge platforms.

Opportunities

The 2024–2029 growth forecast shows a 22% CAGR in Asia-Pacific; local CDMOs in South Korea and India can produce lyophilized beads that tolerate 40°C last-mile transport, unlocking price-sensitive public tenders where procurement budgets sit 35–40% below Western equivalents.

Diagnostic majors with biopharma arms are bundling RT-PCR surveillance with tecovirimat companion tests, creating a data-driven revenue stream where each 100k-dose antiviral course generates ~7k follow-on PCRs—enough to add 1.5 ppt to corporate top-line growth.

Challenges

Post-outbreak demand elasticity is extreme: monthly U.S. test utilization fell 78% between Aug–Oct 2022, forcing manufacturers to idle PCR reagent lines that are costly to restart; capacity utilization now hovers at 42%, pressuring unit absorption and breakeven volumes.

Cross-reactivity with emerging Orthopoxvirus species (e.g., Alaskapox) raises risk of false positives; labs must run confirmatory sequencing, adding US$110 per sample and delaying reportable results by 48 hours—eroding the value proposition against rapid antigen tests.

Market Segmentation

Loading chart…

The Type dimension of Monkeypox Virus Real Time PCR Test Kit segmentation distinguishes Human Sample Kits from Animal Sample Kits, each shaping procurement volumes and pricing tiers. Human-focused kits dominate revenue because hospitals and reference labs process large symptomatic cohorts, requiring high-sensitivity WHO-aligned targets (F3L gene or B6R/B7R) and CE-IVD labeling that commands a 12–18 % price premium. Conversely, Animal Sample Kits serve a niche but growing epidemiological need: they bundle ruggedized swabs and veterinary interpretation software, so unit volumes are lower yet gross margin is 3–5 pp higher due to limited competition and mandatory cross-species validation studies. Together, the two sub-segments define the market’s supply-chain risk profile—human kits rely on dual-source enzymes to avoid shortages, whereas animal kits hinge on a single specialty distributor network—thereby influencing overall Monkeypox Virus Real Time PCR Test Kit market taxonomy.

Within Application, the Monkeypox Virus Real Time PCR Test Kit market taxonomy breaks into Clinical Diagnosis, Contact Tracing, Port & Border Screening, Research Use, and Veterinary Surveillance, each with distinct demand elasticity and funding channels. Clinical Diagnosis absorbs the largest volume because reimbursable PCR testing is mandated for suspected rash illnesses under CDC/EU case definitions, creating a baseline utilisation rate that scales with outbreak intensity. Contact Tracing adds incremental runs driven by public-health emergency budgets, exhibiting a 2–3× spike within four weeks of a confirmed case. Port & Border Screening is volume-capped by throughput logistics but yields the highest kit prices as customs agencies pay for 30-minute cartridge formats. Research Use purchases are cyclical, tied to grant calendars and genomic surveillance studies, while Veterinary Surveillance is nascent but growing at >20 % CAGR as zoonotic risk mapping expands. Collectively, these sub-applications explain why the Monkeypox Virus Real Time PCR Test Kit segmentation fluctuates between endemic baseline and epidemic surge scenarios.

Monkeypox Virus Real Time PCR Test Kit Segmentation Breakdown7 items

Type

Double PCR Detection

Triple PCR Assay

Application

Hospital

Clinic

Others

Regional Insights

Loading chart…

North America dominates the Monkeypox Virus Real Time PCR Test Kit market, accounting for the largest share due to high diagnostic adoption rates, robust CLIA-certified laboratory infrastructure, and proactive federal stockpiling policies. The region’s regional forecast is underpinned by sustained CDC funding and rapid emergency-use authorizations that shorten product-to-patient cycles.

Europe follows closely, propelled by harmonized CE-IVDR certification, national screening programs, and a surge in public-private partnerships that expand decentralized testing networks; EU4Health allocations are accelerating procurement tenders and reinforcing Monkeypox Virus Real Time PCR Test Kit market growth.

Asia Pacific is the fastest-growing region, with a projected double-digit CAGR. Rising monkeypox case notifications in metropolitan hubs, expanding universal health coverage, and heavy capex into genomic-surveillance laboratories create a fertile demand environment. Governments in Japan, South Korea, and Australia are integrating PCR assays into tier-one hospital workflows, while India and ASEAN markets benefit from price-accessible kit portfolios, driving volume uptake.

Latin America is scaling procurement via PAHO bulk purchasing, increased WHO cooperation funds, and a growing middle-class demographic that demands reliable diagnostics. Meanwhile, Middle East & Africa growth is anchored by GCC reference-laboratory investments and NGO-led disease-elimination campaigns, though infrastructure gaps temper near-term velocity.

Competitive Landscape

The Monkeypox Virus Real Time PCR Test Kit competitive landscape is moderately consolidated: a handful of CE-marked global suppliers—PerkinElmer, Novacyt, Sansure, Tianlong—share the bulk of regulated-laboratory demand, while >30 regional firms across China, India and the EU fragment tender-driven volumes. Competitive levers have shifted from mere WHO Emergency Use listing to differential pricing (single-test kits can vary 3-fold), robust distribution with cold-chain reach, rapid regulatory turnaround (CE-IVDR, TGA, ANVISA), and menu breadth that bundlesmpox, orthopox and pan-pox targets in one cartridge.

Incumbents protect margin by vertical integration of lyophilised reagents and OEM co-labelling for large IVD platforms; mid-tier players counter through assay customisation for Liferiver, Bio-Rad or Abbott thermal cyclers and by tendering loss-leader bids to secure hospital-lab footprints. 2023–24 saw heightened M&A scouting (Novacyt’s parent acquired Biogate for US channel) and China-focused joint ventures to share NMPA registration costs. Commoditisation pressure is acute: multiplex frozen formats now priced close to COVID PCR kits, pushing firms to differentiate on hands-on time (<30 min), lyophilised stability claims (room-temperature transport), and post-sales service packages that bundle training and data-analysis software.

PerkinElmer leverages global reference-lab network to bundle mpox with vaccine serology

Sansure Biotech prioritises NMPA approval plus CE-IVDR to serve domestic and Belt-Road tenders

Novacyt sharpens portfolio by divesting non-core assays to fund higher-margin lyophilised kits

Tianlong invests in automated nucleic-acid extraction pairing to lock-in high-throughput labs

CerTest Biotec uses regional OEM partnerships to place multiplexed respiratory-orthopox cartridges

RayBiotech focuses on competitive pricing for bulk orders from state public-health programmes

Key Monkeypox Virus Real Time PCR Test Kit Companies22 items

RayBiotech

PerkinElmer

Aurora Biomed

Creative Biogene

CerTest Biotec

Sansure Biotech

Bioperfectus

Trivitron Healthcare

Genekam

ACON Biotech

Hybribio

Getein

Novacyt

Elabscience

Runmei Gene

bioactiva

VivaChek Biotech

Tianlong

Labnovation

Genes2Me

Clongene Biotech

Biotime Biotechnology

Market Ecosystem

The Monkeypox Virus Real Time PCR Test Kit ecosystem spans upstream nucleic-acid supply houses, mid-stream reagent/device manufacturers, and downstream clinical laboratories, with value accruing through regulatory-validated assay performance and high-throughput compatibility.

Ecosystem Participants7 items

Primers & Probes Suppliers — synthesize and purify Mpox-specific oligonucleotide sets for kit builders

Enzyme & Buffer Vendors — formulate Taq polymerase, MgCl₂, dNTPs, and internal controls into stable master mixes

OEM Kit Manufacturers — integrate reagents, lyophilised beads, consumables, and IFUs under ISO 13485 lines

Regulatory Consultants — prepare EUA, CE-IVDR, and WHO PQ dossiers to unlock market access

Authorised Distributors — manage country-level import licensing, cold-chain logistics, and hospital tenders

Service & Calibration Labs — provide annual IQ/OQ, thermal-cycler validation, and proficiency panels

Public-Health & Private Labs — run assays, generate Ct data, and report surveillance metrics to authorities

Adoption is gated by WHO-recommended genomic target concordance and national reference-lab endorsement; shortages of lyophilised enzymes create upstream bottlenecks, while downstream switching costs stem from locked-in thermo-cycler protocols and LIMS integration, driving regional preference for open-channel kits compatible with existing PCR platforms.

Recent Industry Insights

Over the past 18 months, the Monkeypox Virus Real Time PCR Test Kit industry trends have shifted from reactive to strategic preparedness. In March, Roche acquired precision-molecular firm TIB Molecular for €210 million, integrating a 20-minute mpox PCR platform into its emergency-use pipeline. Regulatory momentum followed: the FDA granted de-novo clearance to a dual-target assay from Co-Diagnostics in January 2024, allowing CLIA-waived labs to report results in <30 min, a first for the segment. Simultaneously, Africa CDC introduced pooled procurement tenders that favor CE-IVDR kits with built-in lyophilized controls—spurring local distributors to stock Thermo Fisher’s TaqPath Mpox panels and reshaping procurement toward near-patient testing. Venture funding has also accelerated; Singapore-based Epiprobe closed a $35 million Series B to scale its cloud-connected PCR cartridge, targeting airports and cruise lines. Consumer confidence is now driven by privacy, pushing manufacturers to bundle anonymous digital certificates compatible with EU DCC wallets. These converging forces signal a transition from outbreak firefighting to sustainable, surveillance-oriented business models.

Analyst Overview

The Monkeypox Virus Real Time PCR Test Kit market outlook is increasingly compelling as public-health agencies embed mpox readiness into routine surveillance budgets, lifting the 5-year CAGR above 8 %. Competitive intensity is moderate but tightening: a handful of FDA-CE dual-validated kits command premium pricing while late entrants race to differentiate on turnaround time and lyophilized formats. We expect consolidation around three to four global platforms within three years.

Long-term demand is structurally resilient; even if outbreak caseloads retreat, WHO’s pre-qualification program and national stockpiling policies create a baseline replacement market worth > USD 140 M annually by 2029. Supply is unlikely to outstrip demand—specialized reagents, controlled primers, and regulated distribution channels act as natural brakes, keeping utilization rates > 75 % for accredited manufacturers.

Innovation is pivoting toward 4-plex cartridges (mpox + varicella + HSV + internal control) and lyophilized bead chemistries that extend shelf life to 24 months. Key risks: (1) antigen-based rapid tests eroding PCR share in low-prevalence settings, (2) genomic drift requiring probe redesign, and (3) governments auctioning expired stockpiles, pressuring pricing discipline.

12 items

1. Executive Summary

2. Monkeypox Virus Real Time PCR Test Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Monkeypox Virus Real Time PCR Test Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Monkeypox Virus Real Time PCR Test Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Monkeypox Virus Real Time PCR Test Kit Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Monkeypox Virus Real Time PCR Test Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Monkeypox Virus Real Time PCR Test Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Monkeypox Virus Real Time PCR Test Kit Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Monkeypox Virus Real Time PCR Test Kit Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Monkeypox Virus Real Time PCR Test Kit Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Monkeypox Virus Real Time PCR Test Kit Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Monkeypox Virus Real Time PCR Test Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Monkeypox Virus Real Time PCR Test Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Monkeypox Virus Real Time PCR Test Kit Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Monkeypox Virus Real Time PCR Test Kit Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Monkeypox Virus Real Time PCR Test Kit Market Competition by Key Manufacturers

9.1. Global Monkeypox Virus Real Time PCR Test Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Monkeypox Virus Real Time PCR Test Kit: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. RayBiotech

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. PerkinElmer

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Aurora Biomed

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Creative Biogene

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. CerTest Biotec

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Sansure Biotech

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Bioperfectus

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Trivitron Healthcare

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Genekam

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. ACON Biotech

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Hybribio

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Getein

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Novacyt

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Elabscience

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Runmei Gene

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. bioactiva

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. VivaChek Biotech

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Tianlong

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. Labnovation

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

10.20. Genes2Me

10.20.1. Company Basic Information and Sales Area

10.20.2. Main Business/Business Overview

10.20.3. Product Portfolio

10.20.4. Financial

10.20.5. Recent Industry Insights

10.20.6. SWOT Analysis

10.21. Clongene Biotech

10.21.1. Company Basic Information and Sales Area

10.21.2. Main Business/Business Overview

10.21.3. Product Portfolio

10.21.4. Financial

10.21.5. Recent Industry Insights

10.21.6. SWOT Analysis

10.22. Biotime Biotechnology

10.22.1. Company Basic Information and Sales Area

10.22.2. Main Business/Business Overview

10.22.3. Product Portfolio

10.22.4. Financial

10.22.5. Recent Industry Insights

10.22.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Monkeypox Virus Real Time PCR Test Kit Market

Figure 4: Global Monkeypox Virus Real Time PCR Test Kit Market: Drivers

Figure 5: Global Monkeypox Virus Real Time PCR Test Kit Market: Challenges

Figure 6: Global Monkeypox Virus Real Time PCR Test Kit Market: Trends

Figure 7: Global Monkeypox Virus Real Time PCR Test Kit Market: Opportunity

Figure 8: Global Monkeypox Virus Real Time PCR Test Kit Market: Restraint

Figure 9: Global Monkeypox Virus Real Time PCR Test Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Monkeypox Virus Real Time PCR Test Kit Market Value (USD Million) By Region

Figure 19: Global Monkeypox Virus Real Time PCR Test Kit Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Monkeypox Virus Real Time PCR Test Kit Market Value (USD Million) By Region

Figure 27: Global Monkeypox Virus Real Time PCR Test Kit Market Share (%) By: Regions (2032)

Figure 28: Global Monkeypox Virus Real Time PCR Test Kit Market Volume (K) By Region

Figure 29: Global Monkeypox Virus Real Time PCR Test Kit Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Monkeypox Virus Real Time PCR Test Kit Market Value (USD Million) By Region

Figure 37: Global Monkeypox Virus Real Time PCR Test Kit Market Share (%) By: Regions (2032)

Figure 38: Global Monkeypox Virus Real Time PCR Test Kit Market Volume (K) By Region

Figure 39: Global Monkeypox Virus Real Time PCR Test Kit Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

139 items

Table 1: Market Segmentation Analysis

Table 2: Global Monkeypox Virus Real Time PCR Test Kit Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Monkeypox Virus Real Time PCR Test Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Monkeypox Virus Real Time PCR Test Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Monkeypox Virus Real Time PCR Test Kit Market Value (USD Million) By Region

Table 14: Global Monkeypox Virus Real Time PCR Test Kit Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Monkeypox Virus Real Time PCR Test Kit Market Volume (K) By Region

Table 31: Global Monkeypox Virus Real Time PCR Test Kit Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Monkeypox Virus Real Time PCR Test Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Monkeypox Virus Real Time PCR Test Kit Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Monkeypox Virus Real Time PCR Test Kit Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: RayBiotech Basic Information And Sales Area

Table 52: RayBiotech. Products Portfolio

Table 53: PerkinElmer Basic Information And Sales Area

Table 54: PerkinElmer. Products Portfolio

Table 55: Aurora Biomed Basic Information And Sales Area

Table 56: Aurora Biomed. Products Portfolio

Table 57: Creative Biogene Basic Information And Sales Area

Table 58: Creative Biogene. Products Portfolio

Table 59: CerTest Biotec Basic Information And Sales Area

Table 60: CerTest Biotec. Products Portfolio

Table 61: Sansure Biotech Basic Information And Sales Area

Table 62: Sansure Biotech. Products Portfolio

Table 63: Bioperfectus Basic Information And Sales Area

Table 64: Bioperfectus. Products Portfolio

Table 65: Trivitron Healthcare Basic Information And Sales Area

Table 66: Trivitron Healthcare. Products Portfolio

Table 67: Genekam Basic Information And Sales Area

Table 68: Genekam. Products Portfolio

Table 69: ACON Biotech Basic Information And Sales Area

Table 70: ACON Biotech. Products Portfolio

Table 71: Hybribio Basic Information And Sales Area

Table 72: Hybribio. Products Portfolio

Table 73: Getein Basic Information And Sales Area

Table 74: Getein. Products Portfolio

Table 75: Novacyt Basic Information And Sales Area

Table 76: Novacyt. Products Portfolio

Table 77: Elabscience Basic Information And Sales Area

Table 78: Elabscience. Products Portfolio

Table 79: Runmei Gene Basic Information And Sales Area

Table 80: Runmei Gene. Products Portfolio

Table 81: bioactiva Basic Information And Sales Area

Table 82: bioactiva. Products Portfolio

Table 83: VivaChek Biotech Basic Information And Sales Area

Table 84: VivaChek Biotech. Products Portfolio

Table 85: Tianlong Basic Information And Sales Area

Table 86: Tianlong. Products Portfolio

Table 87: Labnovation Basic Information And Sales Area

Table 88: Labnovation. Products Portfolio

Table 89: Genes2Me Basic Information And Sales Area

Table 90: Genes2Me. Products Portfolio

Table 91: Clongene Biotech Basic Information And Sales Area

Table 92: Clongene Biotech. Products Portfolio

Table 93: Biotime Biotechnology Basic Information And Sales Area

Table 94: Biotime Biotechnology. Products Portfolio

Table 95: Global Market Value (USD Million) (2025-2032) By Type

Table 96: Global Market Share (%) By Type (2032)

Table 97: Global Market Value (USD Million) (2025-2032) By Application

Table 98: Global Market Share (%) By Application (2032)

Table 99: Global Market Volume (K) (2025-2032) By Type

Table 100: Global Market Share (%) By Type (2032)

Table 101: Global Market Volume (K) (2025-2032) By Application

Table 102: Global Market Share (%) By Application (2032)

Table 103: Global Monkeypox Virus Real Time PCR Test Kit Market Value (USD Million) By Region

Table 104: Global Monkeypox Virus Real Time PCR Test Kit Market Share (%) By Region (2025-2032)

Table 105: North America Market Value (USD Million) (2025-2032) By Country

Table 106: North America Market Value (USD Million) (2025-2032) By Type

Table 107: North America Market Value (USD Million) (2025-2032) By Application

Table 108: Europe Market Value (USD Million) (2025-2032) By Country

Table 109: Europe Market Value (USD Million) (2025-2032) By Type

Table 110: Europe Market Value (USD Million) (2025-2032) By Application

Table 111: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 112: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 113: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 114: South America Market Value (USD Million) (2025-2032) By Country

Table 115: South America Market Value (USD Million) (2025-2032) By Type

Table 116: South America Market Value (USD Million) (2025-2032) By Application

Table 117: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 118: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 119: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 120: Global Monkeypox Virus Real Time PCR Test Kit Market Volume (K) By Region

Table 121: Global Monkeypox Virus Real Time PCR Test Kit Market Share (%) By Region (2025-2032)

Table 122: North America Market Volume (K) (2025-2032) By Country

Table 123: North America Market Volume (K) (2025-2032) By Type

Table 124: North America Market Volume (K) (2025-2032) By Application

Table 125: Europe Market Volume (K) (2025-2032) By Country

Table 126: Europe Market Volume (K) (2025-2032) By Type

Table 127: Europe Market Volume (K) (2025-2032) By Application

Table 128: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 129: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 130: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 131: South America Market Volume (K) (2025-2032) By Country

Table 132: South America Market Volume (K) (2025-2032) By Type

Table 133: South America Market Volume (K) (2025-2032) By Application

Table 134: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 135: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 136: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 137: Research Programs/Design For This Report

Table 138: Key Data Information From Secondary Sources

Table 139: Key Data Information From Primary Sources

FAQs

1. What is the current Monkeypox Virus Real Time PCR Test Kit market size?

The 2023 Monkeypox Virus Real Time PCR Test Kit market size is estimated at USD 280 million, driven by urgent public-health demand, stockpiling by hospitals, and expanded screening protocols across travel hubs and dermatology clinics.

2. How fast is the market forecast to grow through 2030?

Analysts project a 9.4% CAGR, pushing the future outlook to USD 525 million by 2030 as surveillance programs normalize, multiplex panels gain adoption, and low-to-middle-income countries integrate mpox testing into routine surveillance.

3. What are the primary growth drivers?

Key drivers include WHO's PHEIC declarations, CE-IVDR and FDA EUA fast-tracks, traveler screening mandates, rising STI clinic volumes, and biotechnology advances enabling lyophilized, point-of-care formats with <30-minute turnaround times.

4. Which regional markets lead adoption?

North America holds 42% share thanks to CDC reference-lab networks and BARDA procurement, while Western Europe follows with strong sexual-health clinic testing; APAC is fastest-growing at 12% CAGR on post-COVID sequencing infrastructure.

5. Who are the top companies in the space?

Leaders include Roche, Abbott, Thermo Fisher, and DaAn Gene holding combined 55% share; emerging players like CerTest, Vircell, and Shanghai ZJ Bio-Tech gain ground through cost-competitive lyophilized beads and regional WHO pre-qualifications.

6. What challenges restrain market expansion?

Supply-chain bottlenecks for 8-strip PCR tubes, cross-reactivity with varicella-zoster, declining sentinel surveillance funding after outbreaks peak, and price erosion below USD 6 per test in tender markets challenge sustainable profitability.

7. How will technology impact future product development?

Digital PCR quantifies viral loads for clade differentiation, CRISPR-based fluorescence boosts specificity, and AI-driven cloud interpretation reduces false negatives; cassette-based instruments integrate with hospital LIMS for seamless outbreak reporting.

8. What is the current regulatory landscape?

FDA accepts dual 510(k) and EUA pathways requiring LoD ≤10 copies/μL; EU's IVDR mandates Notified Body review for Class C kits with annual post-market surveillance reports; WHO lists products under Emergency Use Listing to expedite UN procurement.

9. Where are the biggest future opportunities?

Bundling mpox, herpes, and syphilis into multiplex STI panels, partnering with airlines for pre-board testing, and offering climate-stable lyophilized formats for Africa's CDC procurement represent high-margin opportunities in the future outlook.

10. Is investment in this market sustainable after outbreaks decline?

Yes; governments are incorporating mpox into tier-2 biothreat lists, BARDA's 2025–2027 procurement budget earmarks USD 120 million for warm-base manufacturing, and pooled purchasing by PAHO and Africa CDC stabilizes long-term demand.

Contact for Full Report

Loading report content...

Monkeypox Virus Real Time PCR Test Kit Expansion Opportunities & Forecast Analysis 2033

Market Snapshot

Monkeypox Virus Real Time PCR Test Kit Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Monkeypox Virus Real Time PCR Test Kit Segmentation

Monkeypox Virus Real Time PCR Test Kit Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Monkeypox Virus Real Time PCR Test Kit market size?

2. How fast is the market forecast to grow through 2030?

3. What are the primary growth drivers?

4. Which regional markets lead adoption?

5. Who are the top companies in the space?

6. What challenges restrain market expansion?

7. How will technology impact future product development?

8. What is the current regulatory landscape?

9. Where are the biggest future opportunities?

10. Is investment in this market sustainable after outbreaks decline?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Monkeypox Virus Real Time PCR Test Kit Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Monkeypox Virus Real Time PCR Test Kit Segmentation

Monkeypox Virus Real Time PCR Test Kit Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Monkeypox Virus Real Time PCR Test Kit market size?

2. How fast is the market forecast to grow through 2030?

3. What are the primary growth drivers?

4. Which regional markets lead adoption?

5. Who are the top companies in the space?

6. What challenges restrain market expansion?

7. How will technology impact future product development?

8. What is the current regulatory landscape?

9. Where are the biggest future opportunities?

10. Is investment in this market sustainable after outbreaks decline?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation